A successful cesarean delivery without fetal or maternal morbidity in an Eisenmenger patient with cor triatriatum sinistrum, double-orifice mitral valve, large ventricular septal defect, and single ventricle who was under long-term bosentan treatment

Turk Kardiyol Dern Ars. 2017 Mar;45(2):184-188. doi: 10.5543/tkda.2016.17747.

Abstract

Presently described is successful cesarean delivery in a pregnancy superimposed on long-term bosentan treatment in an Eisenmenger syndrome patient with cor triatriatum sinistrum, double-orifice mitral valve, and large ventricular septal defect resulting in single functioning ventricle with double outlets. Cesarean delivery was performed at 27th week of gestation without maternal or fetal morbidity. The infant had no congenital cardiovascular abnormality or any probable teratogenic effect of bosentan treatment during pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bosentan
  • Cardiovascular Agents / therapeutic use
  • Cesarean Section*
  • Cor Triatriatum / complications*
  • Cor Triatriatum / drug therapy
  • Eisenmenger Complex / complications
  • Eisenmenger Complex / drug therapy
  • Female
  • Heart Septal Defects, Ventricular / complications*
  • Humans
  • Infant, Extremely Premature*
  • Infant, Newborn
  • Sulfonamides / therapeutic use*

Substances

  • Cardiovascular Agents
  • Sulfonamides
  • Bosentan